Abstract
Cerebral ischaemic and haemorrhagic lesions are commonly visualised on MRI studies in older patients. Although there is evidence for their association with cognitive outcome in large series, the utility of their detection for individual prognostication is limited at this stage. Studies which evaluate these findings as a comprehensive suite, with due attention to alternative pathological conditions, especially Alzheimer disease, may improve the understanding of the precise contribution of cerebrovascular disease towards cognitive impairment and dementia, and the potential interdependence of this contribution on the presence and severity of alternative brain pathology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131–144. doi:10.1038/nrneurol.2010.4
Brodtmann A, Pardoe H, Li Q, Lichter R, Ostergaard L, Cumming T (2012) Changes in regional brain volume three months after stroke. J Neurol Sci 322:122–128. doi:10.1016/j.jns.2012.07.019
Colloby SJ, McParland S, O’Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer’s disease and Lewy body dementias. Brain 135:2798–2808
Cordonnier C, van der Flier WM (2011) Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain 134:335–344
de Bruijn RF et al. (2015) Association Between Atrial Fibrillation and Dementia in the General Population JAMA Neurol:1-7 doi:10.1001/jamaneurol.2015.2161
Dickerson BC et al (2009) The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19:497–510
Jack CR et al (2016) Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol 15:56–64. doi:10.1016/s1474-4422(15)00323-3
Klein JC et al (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74:885–892. doi:10.1212/WNL.0b013e3181d55f61
Lee S et al (2016) White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 79:929–939
Miwa K, Tanaka M, Okazaki S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K (2014) Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors. Neurology 83:646–653
Pohjasvaara T et al (2000) How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 57:1295
Prins ND, Scheltens P (2015) White matter hyperintensities, cognitive impairment and dementia: an update Nature reviews. Neurology 11:157–165. doi:10.1038/nrneurol.2015.10
Rowe CC et al (2013) Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Ann Neurol 74:905–913
Schade S, Mollenhauer B (2014) Biomarkers in biological fluids for dementia with Lewy bodies. Alzheimers Res Ther 6:72
Smith M, Nagy Z, Barnetson L, King E-F, Esiri M (2000) Coexisting pathologies in the brain: influence of vascular disease and Parkinson’s disease on Alzheimer’s pathology in the hippocampus. Acta Neuropathol 100:87–94
Stebbins GT et al (2008) Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke 39:785–793
van Dalen JW et al (2015) Cortical microinfarcts detected in vivo on 3 Tesla MRI clinical and radiological correlates. Stroke 46:255–257
van Rooden S et al (2014) Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging. Radiology 270:205–211
van Veluw SJ, Zwanenburg JJ, Engelen-Lee J, Spliet WG, Hendrikse J, Luijten PR, Biessels GJ (2013) In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab 33:322–329. doi:10.1038/jcbfm.2012.196
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348:1215–1222
Vernooij M et al (2008) Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 70:1208–1214
Yassi N et al (2015a) The association between lesion location and functional outcome after ischemic stroke. Int J Stroke 10:1270–1276
Yassi N et al (2015b) Contralesional thalamic surface atrophy and functional disconnection 3 months after ischemic stroke. Cerebrovasc Dis 39:232–241
Yassi N et al (2016) Association between baseline peri-infarct magnetic resonance spectroscopy and regional white matter atrophy after stroke. Neuroradiology 58:3–10. doi:10.1007/s00234-015-1593-6
Yates P, Sirisriro R, Villemagne V, Farquharson S, Masters C, Rowe C (2011) Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology 77:48–54
Yates PA et al (2014) Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology 82:1266–1273
Acknowledgments
N. Yassi is supported by an NHMRC-ARC Dementia Research Development Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yassi, N., Desmond, P.M. & Masters, C.L. Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia. J Mol Neurosci 60, 349–353 (2016). https://doi.org/10.1007/s12031-016-0799-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-016-0799-3